Volume 6, Issue 4 pp. 348-351

Induction of a transient graft vs. leukemia effect following unrelated cord blood transplantation

Paul R. Haut

Paul R. Haut

Division of Hematology/Oncology, Department of Pediatrics, North-western University Medical School, Children's Memorial Hospital, Chicago, Illinois,

Search for more papers by this author
Lydia Gonzalez-Ryan

Lydia Gonzalez-Ryan

Division of Hematology/Oncology, Children's Healthcare of Atlanta, Atlanta Georgia,

Search for more papers by this author
Ling-Jia Wang

Ling-Jia Wang

Division of Gastroenterology, Department of Pediatrics, North-western University Medical School, Children's Memorial Hospital, Chicago, Illinois

Search for more papers by this author
Marie Olszewski

Marie Olszewski

Division of Hematology/Oncology, Department of Pediatrics, North-western University Medical School, Children's Memorial Hospital, Chicago, Illinois,

Search for more papers by this author
Elaine Morgan

Elaine Morgan

Division of Hematology/Oncology, Department of Pediatrics, North-western University Medical School, Children's Memorial Hospital, Chicago, Illinois,

Search for more papers by this author
Morris Kletzel

Morris Kletzel

Division of Hematology/Oncology, Department of Pediatrics, North-western University Medical School, Children's Memorial Hospital, Chicago, Illinois,

Search for more papers by this author
First published: 21 October 2002
Citations: 6
Paul R. Haut, MD,
Assistant Professor of Pediatrics, Stem Cell Transplant Program, Division of Hematology/Oncology, Children's Memorial Hospital, Box 30, 2300 Children's Plaza, Chicago, IL 60614, USA
Tel.: (773) 880–4585
Fax: (773) 880–3223
E-mail: [email protected]

Abstract

Abstract: Umbilical cord blood (UCB) has become a frequent source of allogeneic hematopoietic stem cells for transplantation. Of theoretical concern is a potential decrease in the graft vs. leukemia (GvL) effect, given the lesser degree of graft vs. host disease (GvHD) with this donor source. We report a case of recurrent acute non-lymphoblastic leukemia (ANLL) following stem cell transplantation with unrelated mismatched UCB, which responded to the induction of GvHD. The response was documented both morphologically and by evaluation of chimeric engraftment by molecular DNA techniques. In addition, WT-1, a purported marker of minimal residual disease in acute leukemia, correlated with remission status in this patient. In summary, the GvL effect is seen with allogeneic UCB transplantation and has the potential to be induced along with GvHD.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.